|
Harris ED, Budd RC, Genovese MC, Firestein GS, Sargent JS, Sledge CB, Kelley's Textbook of Rheumatology, 7th ed. St. Louis, MO; W.B. Saunders; 2005.
US Food and Drug Administration. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Rockville, MD: National Press Office; April 7, 2005. Press Release P05-16.
US Food and Drug Administration. FDA Issues Public Health Advisory Recommending Limited Use of Cox-2 Inhibitors. Rockville, MD: National Press Office; December 23, 2004. Talk Paper T04-61.
|